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ABSTRACT 
This research was made to establish the factors that affected consistency in supply of pharmaceutical products in 
government hospitals in Kenya. In most cases, the government run hospitals have had inconsistency in supply of 
pharmaceutical and previous researchers have not identified the reasons culminating to such situations regardless 
of the huge amounts of budget allocations. The study was carried out in Maragua district hospital with a sample 
size of 100 individuals comprising of management, procurement department, nursing department and the 
pharmacy department personnel. The researcher used stratified random sampling. Structured questionnaires were 
given out to the respondents to fill and the researcher conducted unstructured interviews. Data collected was 
analysed and it was clear that the procurement process and its management, legal requirements and internal tools 
used for enhancing procurement greatly determined the timely availability of supplies following.   
The researcher identified that the procurement department was understaffed and procurement process was at 
times not observed. Financing was a major problem. Legal requirements were bureaucratic and lengthened the 
procurement process leading to inconsistency in obtaining supplies.  The hospital had no core tool for enhancing 
procurement performance. The legal framework needed review to reduce bureaucracy and shorten the process 
and training on procurement issues to all hospital procurement players was required to boost their knowledge. 
The hospital faced several challenges, which included shortage of staff in the procurement department and 
financial constrains. 
DEFINITION OF TERMS 
Supply supply is the quantity of goods and services that a producer is willing and able to produce for market 
transaction at a given price in a given time period (Dobler, 1996). 
Shock demand  Any sudden event that dramatically but (usually) temporarily increases or decreases demand for 
one or more goods or services. The event may result from government intervention, such as a change in money 
supply, or may be a random occurrence in the market (Rivard, 2002). 
Procurement   This is the acquisition of goods and/or services at the best possible total cost of 
ownership, in the right quality and quantity, at the right time, in the right place and from the right source for the 
direct benefit or use of corporations, individuals, or even governments (Dobler, 1996). 
Pharmaceuticals Also referred to as medicine, medication or medicament, can be defined as any chemical 
substance intended for use in the medical diagnosis, cure, treatment, or prevention of disease (US, 2008). 
Product This is  anything acquired either as tangible or intangible which closely meets the requirements of a 
particular need and yield enough satisfaction to justify its continued existence. (Kotler, & Adam, 2006) 
Consistency the ability of the supplier to demonstrate a high standard of delivery reliability and quality, 
preferably with evidence of improvement over time (Carter & Kirby, 2006)  
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CHAPTER ONE 
INTRODUCTION 
This chapter contains the overall overview of the research project. It contains the background of the study, 
statement of the problem, objectives of the study, research questions, scope of the study, significance of the 
study and limitations of the study. 
 
1.1 Background of study 
Advances in pharmaceuticals have transformed health care over the last several decades. Today, many health 
problems are prevented, cured, or managed effectively for years through the use of prescription drugs. In some 
cases, the use of prescription medicines keeps people from needing other expensive health care such as being 
hospitalized or having surgery (zhang & Soumeral, 2007). Furthermore, the drug industry’s profit margins have 
raised considerable attention. Pharmaceutical manufacturing was the most profitable industry in the U.S. from 
1995 to 2002, and in 2008 it ranked third with profits after taxes of about 19 percent (US, 2007). Several factors 
have contributed to this growth in spending on pharmaceuticals, including: 
Increased utilization and demand for prescription drugs - From 1999 to 2009, the number of prescriptions 
purchased in the United States increased 39% (Kaiser, 2008). 
Types of prescriptions written – Most of the top-selling prescriptions are newer, higher-priced brand name drugs 
that have replaced older, less-expensive drugs.  
Price increases - Retail prescription prices have increased on average 3.6% annually between 2000 and 2009, 
much faster than the average inflation rate of 2.5%.  
 
Research and Development – Manufacturers try to recoup the research and development, costs for drugs that 
make it to the market as well as those that do not enter the marketplace.  Only one in five drugs that make it to 
the clinical testing process receive FDA approval and are brought to market (Di masi, 2003).  
Advertising and Marketing - Pharmaceutical manufacturers make substantial investments on marketing to 
consumers and physicians, which may influence consumer demand and physician prescribing practices. 
Furthermore, the most heavily advertised products tend to be newer, more expensive drugs. This results in 
overall increases in spending.  
The role of patent laws in drug pricing is also an important factor.  Patent protection provides manufacturers an 
exclusive right to sell new drug products for up to 20 years from the date of the patent filing. Once the patent 
expires, the drug may be manufactured in generic versions by any number of manufacturers, thus lowering the 
prices for the drug. Pharmaceutical companies have been accused of obtaining a new patent on a slightly 
different version of a drug about to go off patent to extend their favorable market situation, and these patent 
protections have garnered criticism by some groups for limiting access to competition and making some life-
saving medications unavailable and unaffordable for patients (frank, 2007). 
Rising prescription costs have led many to call for greater government involvement in regulating the 
pharmaceutical industry, particularly since prices for brand pharmaceutical products are considerably higher in 
the U.S. than in countries where governments take a more active role in negotiating prices and regulating 
profits.  
Opponents however, argue that government involvement will not guarantee lower prices, may have unintended 
consequences for the rest of the market, and would negatively affect patients because regulatory actions would 
stifle industry incentives to invest in research and development of new therapies. 
The health system in Kenya is organized and implemented through a network of facilities organized in a 
pyramidal pattern. The network starts from dispensaries and health clinics/ posts at the bottom, up to the health 
centers, sub-district hospitals, district hospitals, provincial general hospitals and at the apex there is the Kenyatta 
National Hospital. The Ministry of Health (MoH) is the major financier and provider of health care services in 
Kenya. Out of all the health facilities in the country, the MoH controls and runs about 52% while the private 
sector, the mission organizations and the Ministry of Local government runs the remaining 48%. The public 
sector controls about 79% of the health centers, 92% of the sub-health centers, and 60% of the dispensaries. The 
NGO sector is dominant in health clinics, maternity and nursing homes controlling 94% of the total while also 
controlling 86% of the medical centers in the country (CBS, 2004). 
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Kenya spends about 8% of its GDP on health. Per capita expenditure per person stood at about US$ 11 per 
person in 2003. Out of this, US$ 6 came from budgetary resources, which also included donor contributions and 
the balance of about US $5 came mainly from out-of-pocket expenditure. This expenditure fell far below the 
WHO’s recommended US$34 per capita. Out-of pocket expenditure thus accounted for 53% of the total cost of 
healthcare, with the remainder being Government contributions from general taxation (25%), Social Health 
Insurance (15%), private prepaid health plans (5%) and non-profit institutions expenditure at 2%. The above 
scenario means the current healthcare financing system depends mainly on out-of-pocket expenditure and 
therefore 75% privately financed. 
The efforts at different levels to control diseases have seen the adoption of the Directly Observed Treatment 
Short-course (DOTS) as a national strategy in Kenya to contain Tuberculosis. The treatment success rate had 
improved to about 80% by end of 2003.  
While there are a number of policy options under consideration for addressing rising drug costs, the two that are 
currently receiving the most attention from policymakers involve the government's role in drug pricing for the 
Medicare program and importation from other countries. 
Government's role in Medicare drug prices is major issue currently under debate involves the appropriate role for 
government regarding drug prices for Medicare beneficiaries under the Part D drug benefit. The law specifically 
prohibits the government from participating in negotiations between the drug plan sponsors and drug 
manufacturers and pharmacies, establishing any specific list of drugs that will be covered (formulary), or 
imposing any price controls on drugs. Supporters of this market based approach believe that the competition for 
enrollees will cause plans to negotiate with drug manufacturers and pharmacies to offer drugs at the lowest 
possible prices, while opponents state that the lack of federal regulation and negotiating power will lead to 
higher costs for Medicare and for Medicare beneficiaries, many of whom still face sizable out-of-pocket costs for 
prescription medications (WHO,2008) 
The significantly lower prices available for common brand name prescription drugs in Canada and other 
countries has led some individuals as well as state governments to import drugs from those countries. 
Prescription drug importation is illegal in most cases. A number of proposals on importation have been 
introduced in varying in scope, the countries from which drugs could be imported, safety standards, regulatory 
requirements, and fees that would be levied to help pay the costs of increased government regulation. Supporters 
believe that if importation were legal from other countries, including Canada and the Asian and European 
markets, there would be enough volume to significantly affect prices in the worlds market. Opponents question 
the safety of imported drugs and caution that cost savings would be small if foreign governments were to restrict 
the supply of drugs leaving their borders or pharmaceutical manufacturers limited the supply of drugs sold to 
foreign nations. 
1.2 Problem statement 
This study explored the factors affecting the consistent supply of pharmaceutical products in government 
hospitals in order to identify the cause for frequent shortages in these hospitals. Due to lack of constant supplies, 
most of the hospitals had been experiencing time-to-time shortages of pharmaceuticals therefore being not in a 
position to deliver better health care to patients. According to a study commissioned by Transparency 
International-Kenya, (2001) the shortage was creating a trail of misery for patients across the country. In most 
hospitals, patients had been asked to buy them from private chemists. In an effort to stabilize the supply of 
pharmaceuticals products, KEMSA was set-up by the government in the year 2000 to procure and supply drugs 
and pharmaceutical supplies to public, mission and private hospitals in the country. Lead Consultant, observed 
that the government needed to put more resources in health care so that it can be in line with the Abuja 
declaration, which states that at least 15 per cent of the national budget should go to provision of healthcare. The 
study points out that KEMSA lack the institutional capacity, autonomy, financial and human resources capacity 
to perform its mandate effectively.  
For effective operations in any institution, supplies should be available when needed. Proper stock control 
records enable organizations to eliminate stock outs by ensuring timely ordering of stocks. Having formed 
KEMSA to be in charge of pharmaceutical products distribution in Kenya, the government had taken a move 
towards achieving consistency in supply in government hospitals. However, this had not been achieved. In 
consistency in supply of pharmaceutical products engulf government hospitals in Kenya. The factors culminating 
to this state of affairs had not been well identified and this research therefore sought to unearth this factors.   
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1.3 General objective 
To establish the factors that affect consistency in supply of pharmaceutical products in government hospitals in 
Kenya.  
1.3.1 Specific objectives 
i. To identify the effects of procurement process and its management on consistency in supply 
ii. To determine the influence of legal policy on consistency in supply of pharmaceuticals 
iii. To identify methods of enhancing the process of procurement to achieve consistency 
1.4 Research questions 
i. How do the procurement process and its management affect consistency in supply?  
ii. How does the legal framework influence the procurement of pharmaceutical products? 
iii. What measures can be taken to improve the procurement process to achieve consistency in supply? 
   
1.5 The significance of the study 
The study was made to unearth the causes of the unstable supply of pharmaceuticals products in government 
hospitals. In that case be in a position to identify what hindrances were faced and therefore formulate best 
institutional policies and regulations that can sustain constant supplies. This study is significant at this time when 
the governmental hospitals are faced with great challenge of handling huge Kenyan population who require 
better services. In consideration to this, the results of this study are believed to be of great benefit to: 
 A. Investors 
After obtaining the basic enlightenment highlighted out in this study, investors will obtain knowledge; hence due 
to the demand of doing business , willing and able investors will be in apposition to make use of the information 
and make sound decisions while venturing in the pharmaceuticals business. 
 B. Management 
The management shall be acquainted with major issues that affect the supply of pharmaceutical products in their 
hospitals; and therefore be in a position to make sound judgments and decisions on how to counter them. In 
addition ensure smooth running of the hospitals by ensuring all required pharmaceuticals are availed when 
needed hence no stock outs and un warranted overstocking which can lead to expiry of products. 
 C. The public 
The public shall be informed of the causes leading to the un availability of proper medical care in government 
hospitals. 
 D. Government 
The government being in charge of delivering proper medical care to its citizens; the finding of this research will 
facilitate in formulating and putting in place best practices to ensure all hospitals receive supplies. Having 
deployed great effort to achieving better medication for all Kenyans, the government will be able to asses its 
performance. 
1.6. The scope of the study 
The research focused on the factors that affected the consistency in the supply of pharmaceutical products in 
government hospitals. The research therefore was conducted in Maragua level 4 Hospital in Murang’a County as 
an example of a government run hospital.  
 
1.7. Limitations of the study 
Due to personal attitudes, individual values and organizational policies, practitioners’ in the medical profession 
keep most of there undertaking secret. The researcher received minimal cooperation from some respondents. The 
un availability of target respondents due to their busy schedules was a major challenge. Therefore, accessibility 
of records was limited; hence limiting the availability of more information that would have permit elaborate 
research. 
 Resource constrains also posed a great limitation; with constrained finances and very busy schedules therefore 
the researcher having limited time to carry out the research.  
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CHAPTER TWO 
LITERATURE REVIEW 
2.0 Introduction  
This chapter presents the literature review of the main concepts in relation to supply of pharmaceutical products, 
and the conceptual framework of the study 
 
2.1 Theoretical frame work 
2.1.1 Inventory management  
In order to help hospitals ensure constant availability of pharmaceutical product, good inventory management 
system is key to the success in the steady availability of supplies. Several systems are available for use as 
observed by various scholars. In a standard hospital supply chain, all material operations are controlled by the 
hospital. Material personnel include purchasers, material handlers, and stockroom personnel. Other personnel, 
mainly nurses, technicians, and pharmacists, also spend a significant amount of time with material operations. 
Purchasers and material handlers are typically assigned to one or more wards within a hospital. Material from the 
hospital’s various suppliers is delivered in bulk to the hospital’s loading dock and transported to a main store 
room. Material handlers then transport material from the main store room to various secondary store rooms in 
wards throughout the hospital as the inventory in those wards diminishes. Typically, hospitals do not track 
perpetual inventory, but rather use visual cues to decide when to place an order for more material. The standard 
hospital supply chain is characterized as having inflated inventories (6 – 8 weeks) and a high occurrence of stock 
outs (90-95% fill rate). In general, medical staff has no incentive or time to be concerned with efficient material 
operations as they are much more concerned with taking care of patients. In addition, the lack of any inventory 
system makes it virtually impossible for the personnel to know which inventory is in excess and which short is, 
as they have no visibility into the inventories that are scattered all over (Rivard, 2002). 
 
2.1.2. Stockless inventory  
Under a stockless program, the distributor delivers product in pieces rather than bulk. The hospital is still 
responsible for placing the orders. Orders are transmitted from individual wards, and the material is delivered 
directly to the ward, bypassing the storeroom. Some redundant functions are removed from the supply chain as 
shipments are counted only once (at the distributor) as compare to the old system where each shipment was 
counted twice (at the distributor and at the hospital receiving dock). In essence, as compared with the standard 
supply chain, distributors have assumed the duties of holding inventory and replenishing individual locations. 
The implementation of a stockless system requires a “continuous flow of information between the point of use 
and the distributor” (Rivard & Beaulieu, 2002). 
In addition, under this program, the distributors have more visibility into the actual usage of the hospital; thereby 
reducing the bullwhip effect that is prevalent in many extended supply chains. The bullwhip effect explains that 
demand variations tend to increase as one move up the supply chain. Nathan and Trinkaus noted two hospitals 
with item fill rates over 99%, compared with a conventional average of 92% (Rivard, 2002).  
2.1.3. Vendor managed inventory  
While stockless inventory systems have clear benefits for hospitals with virtually no inventory control, the 
system still does little to optimize operations within the entire supply chain channel. It removes fiscal 
accountability from hospital employees placing orders on the distributors. Order one piece of a particular part 
every day rather than consolidate to weekly shipments of five pieces. In short, there is no incentive for the 
ordering group to be efficient (Marino, 1998). As a result, distributors offer a service of vendor-managed 
inventory (VMI). Under VMI, the distributor hires employees to work in the hospital and assume all material 
operation duties, including material handling, warehousing, and purchasing. The distributor not only purchases 
material from its own facilities, but also from manufacturers and their competitors, as directed by the medical 
staff (Marino, 1998). 
  
2.1.4. Automated point of use systems 
These systems keep perpetual inventory records and automatically place orders based on the established reorder 
and order-up-to points. APU systems apply accountability to those using the inventory; and therefore, reduced 
shrinkage and increase cost capture. Another benefit of APU systems is that they allow for visibility into the 
entire hospital’s inventory. Hence, for common parts, a shortage in one ward can be mitigated with excess 
inventory from another ward until the next replenishment arrives. This is a very significant advantage. Duclos, 
(1993) performed a study that demonstrated that point-of-use safety stock was much less effective than central 
store safety stock in preventing stock-outs during shock demand situations. In her model, as emergency demand 
is a characteristic of many hospitals business model, the study’s conclusions are cause for concern and question 
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the stockless model. However, in this study, Duclos’s model assumed no visibility of inventory from ward to 
ward. The added visibility from APU systems void Duclos’s findings and increase the resiliency of the hospital 
supply chain under emergency demand situations. 
 
2.2. Conceptual framework 
INDEPENDENT VARIABLES   DEPENDENT VARIABLE 
  
Figure: 2.1 conceptual frame work 
. 
2.2.1. Procurement process  
Providing health facilities with drug and medical supplies is a very complex process that involves a large variety 
of actors from both the private and public sectors. Government’s health ministries often lack the management 
skills required to write technical specifications, supervise competitive bidding, and monitor and evaluate the 
contract performance. Corruption can occur at any stage of the process and influence decisions on the model of 
procurement (direct rather than competitive), on the type and volume of procured supplies, and on specifications 
and selection criteria ultimately compromising access to essential quality medicines (Smith, 1990). 
The Kenya Medical Supplies Agency (KEMSA) is established by law as the primary public procurement agency 
for medicines, medical supplies, and medical devices and equipment. It is funded by direct allocation in the 
national budget and by development partners. The procurement process starts with the receipt by KEMSA of 
procurement requests from the relevant department in the Ministry of Health. It then prepares a procurement 
plan, with descriptions, specifications, and quantity of items required by the public institutions. KEMSA’s mode 
of purchase is through open tender or quotations for urgent supplies. For regular procurement, a decision is made 
by the user department and the funding agency on the mode of tendering, i.e. whether it should be local open 
tender or international open tender. Interested companies domiciled in Kenya are eligible for local tendering. The 
next step is the publication of tender notices. These describe the required items and quantities; the procedures to 
be followed for bidding, receipt of samples, and technical evaluation; and the conditions of award. The tender 
notice also provides an opportunity for bidders to seek clarifications and offers the possibility of amendments 
before the tender deadline. There are technical specifications for tender qualification: pharmaceutical 
manufacturers need certification by the national authority with regard to conformance to the WHO certification 
scheme and GMP. All products must be currently registered with the Pharmacy and Poisons Board. Evidence is 
required for bio-availability and/or bio-equivalence for certain critical items, upon request. There are several 
other requirements with regard to packaging, labeling, etc (WHO, 2008). 
At the close of the tender period, KEMSA carries out commercial and technical evaluation of the bids. Before an 
award is made, it appoints a technical evaluation committee to assess the bids’ compliance with product 
specifications and other GMP/certification requirements. The assessments are submitted to a tender committee 
that awards the contract on the basis of lowest price amongst the bids of acceptable quality. Supplies are 
delivered to KEMSA warehouses where they are again evaluated on receipt and before storage. KEMSA, in 
conjunction with the user department, prepares a distribution list. Distribution is made mainly to public health 
institutions and KEMSA outsources transport for deliveries to the health facilities (MOH & CBS, 2004). 
Effects of Procurement 
process and its 
management 
CONSISTENT        
SUPPLY OF 
PHARMACEUTICALS 
 
 Methods of enhancing 
Procurement Process 
Influence of Legal 
policy and regulations 
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The pattern of procurement at KEMSA has recently been changed following the emergence of various problems 
in the process in recent years. In the past, KEMSA had, in some years, procured above budget. This resulted in 
unpaid bills from one year having to be carried over and settled out of the following year’s budget allocation. 
This procedure then created budgetary shortfalls in the succeeding year. Moreover, money allocated by Treasury 
for purchase of pharmaceuticals but not spent in a budgetary year automatically reverts to the Treasury on 30 
June each year. To avoid this situation, transfers were made to KEMSA’s account from the Ministry of Health 
before financial year-end so that it would appear that the funds had already been spent. In order to resolve this 
anomaly, both KEMSA and the Task Force report recommend the establishment of a special fund as already 
provided for in the Act establishing KEMSA. In an attempt to resolve this problem, tenders covering a two-year 
period instead of just one are now advertised (MOH, 2004). 
There is also provision to procure only a portion of the total quantity specified in the tender, according to the 
needs, priority and available funds. A joint survey funded by USAID, the Millennium Challenge consortium, and 
Management Sciences for Health was carried out in 2007/8 to compare KEMSA’s procurement prices with those 
of the Mission for Essential Drugs and Supplies, Kenyatta National Hospital, and local manufacturers and 
distributors. One of the purposes was to determine whether KEMSA and the Ministry of Medical Services were 
getting value for money in public procurement. The conclusion was that, for the most part, KEMSA prices are 
more competitive than for similar products purchased by health facilities from all the other entities surveyed, and 
that KEMSA was indeed achieving value for public-funded procurement of medical commodities (MOH, 2004). 
It has been estimated that KEMSA’s purchases constitute 30 per cent of all prescription drugs in the Kenyan 
market. The Agency also procures for some donor partners. KEMSA’s 2010/2011 Government budget (not 
counting donor contributions) for the procurement of essential medicines for public hospitals is US$ 19.8 
million; together with US$ 29.7 million for Rural Health Facilities, this makes a total of US$ 49.5 million. Out 
of 343 items on the Essential Drug List (EDL), KEMSA procures only about 117 selected items, based on 
available funds. Many EDL medicines can not be purchased because of budgetary constraints (CBS &MOH, 
2004). 
Mission for Essential Drugs and Supplies (MEDS) is another large-scale, bulk procurer of medicines. It is a not-
for-profit organization, which procures medical items for Faith-Based Organizations (FBO) and some donors. 
About 45 per cent of MEDS’ annual turnover of 800 million to 1 billion KSh (about US$ 12 million) is spent on 
medicines. Some donors procure directly.  
 
2.2.2 Legal & regulatory framework 
The organization of Kenya's health care delivery system revolves around three levels, namely: 
The MOH headquarters - The headquarter sets policies, coordinates the activities of NGOs and manages, 
monitors and evaluates policy formulation and implementation. 
The provinces - The provincial tier acts as an intermediary between the central 
Ministry and the Districts. It oversees the implementation of health policy at the district level, maintains quality 
standards and coordinates and controls all district health activities. In addition, it monitors and supervises 
District Health Management Boards (DHMBS), which supervise the operations of health activities at the district 
level. 
The Districts - district level concentrates on the delivery of health care services and generates their own 
expenditure plans and budget requirements based on the guidelines from the headquarters through the provinces. 
Other key players in the healthcare sector include the private sector, which consists of the churches, private 
healthcare providers, pharmaceutical companies, NGOs, and the traditional herbal medical practitioners (MOH, 
2004). 
 
2.2.3. Policy on pharmaceuticals 
The patent protection of pharmaceuticals in Kenya is based on the African Regional Industrial Property 
Organization (ARIPO) patent system. Kenya’s patent laws have been revised from the traditional British based 
format to the ARIPO system, which was created by the Lusaka agreement in 1976. To date several amendments 
have been made through parliament bills and enacted. 
ARIPO is based in Harare, Zimbabwe; the organisation was mainly established to pool the resources of its 
member countries in industrial property matters together in order to avoid duplication of financial and human 
resources. Additionally, the Kenyan government passed the Kenya Industrial Property Bill in 2001. This bill 
allows Kenya to import and to produce more affordable medicines for HIV/AIDS and other diseases (MOH, 
2004). 
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2.2.4. Registration of medicines and other pharmaceuticals 
Market approval (or registration) of pharmaceutical products is usually granted based on efficacy, safety and 
quality. It is a regulatory decision that allows a medicine to be marketed in a given country. Compliance with 
regulations affecting drug licensing, accreditation and approvals can be costly for pharmaceutical companies 
wanting to market their products. Some of them may try to bribe or influence the regulator to get their product 
registered or simply to speed up the approval process. One form of influence is to offer lucrative industry jobs or 
consulting assignments to regulatory officials, rewarding them for decisions that are favorable to industry. Such 
conflict of interest can also affect the setting of user fees for drug registration, which are often set well below 
true cost. Thus, government is effectively subsidizing costs of private industry for little public benefit. The 
concept of conflict of interest is not always well understood (Kaplan & Laing, 2003).  
 
2.2.5. Procurement procedures  
Every organization that purchases goods or services has standard procurement procedures, the methods they use 
to acquire those things. These procedures cover all aspects of the procurement cycle, including the selection of 
the supplier, contract negotiations, order placement and payment (WHO, 1999). All firms have procurement 
procedures, and they are used to control spending activity, ensure appropriate approvals are in place and reduce 
the risk of overpayment. Procurement or purchasing activity encompasses all spending activity, excluding 
payroll, and often represents more than 50 percent of all expenditures. Article 5 of the public procurement act 
outlines the following Procurement Procedures: 
A supplies, services or works contract shall be awarded by means of one of the following procedures under the 
conditions set out in these Rules: Open tendering, Restricted tendering, Competitive request for quotations, 
Negotiated tendering and Direct procurement 
Article 6 of public procurement Act outlines the Conditions for use of the Procurement Procedures 
(a) The Secretariat may award contracts by an open tendering for any procurement regulated by these Rules. 
(b) Restricted tendering may be used in the event of a large or complex procurement, which requires a pre-
qualification procedure. 
(c) In all cases where the contract value exceeds 30 000 (thirty thousands) EUR, the Secretariat shall apply open 
or restricted tendering. 
(d) Competitive request for quotations may be applied if the contract value is less than or equal to 30 000 (thirty 
thousands) EUR. 
(e) Negotiated tendering shall be applied in special cases and only if conditions set forth in Article 7 are met 
(public procurement Act, 2005). 
The primary driving force for the development of procurement procedures is to control all spending (WHO, 
2008). The actual procedures used can vary slightly but will be similar. An appropriate approval process usually 
involves a separation of tasks and the involvement of senior managers for transactions that will cost more than a 
specific price. Another standard procurement procedure is to limit access to the purchase order forms and require 
signed authorization from a manager other than the person using the goods. This separation of the goods 
recipient and the approval is designed to ensure that a senior staff member is aware of the order, can confirm that 
the materials are required, and will be used for the proper purpose.  
 
2.2.6. Distribution and appropriation of pharmaceutical products 
Due to under-financed and badly managed systems, poor record-keeping and ineffective monitoring and 
accounting mechanisms, large quantities of drugs and medical supplies are stolen from central stores and 
individual facilities, and diverted for resale for personal gain in private practices or on the black market (Ferinho, 
2004).This involves a variety of practices such as record falsification, dispensing drugs to "ghost patients", or 
simply pocketing the patient's payment. Patients are directly affected in this process as they are forced to supply 
their own medications. This results in considerable leakage of public resources. Distributing medical supplies to 
the healthcare facilities also involves managing an effective transportation system and preventing 
misappropriation of fuel and vehicles for private or non-health related uses.  
(Rafael & Ernesto, 2002) Measures to reduce illegal practices at the distribution stage of medical supplies 
include establishing efficient inventory control systems, improving record keeping and control procedures, 
fortifying security against robbery in central warehouses, etc. These are actions to be taken by the ministry at 
national and/or provincial/district level. The means of promoting a competitive market or using it, where it 
exists, are other avenues to improve efficiency and reduce corruption in distribution. Rafael and Ernesto (2002) 
has provided many tools for improving drug distribution systems, including guidelines for forecasting, supply 
chain management, process mapping for improved health logistics system performance, and warehousing of 
health commodities.  
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2.2.7. Timely and accurate information communication 
Information is the lifeblood of procurement and is needed at every stage if the procurement process is to be 
optimal. What to order, when to order and how much to order and from who should be communicated on time to 
ensure steady supply in the hospitals. Timely and accurate information exchange is necessary among staff and 
among procurement trading partners. Thus, maintaining an up-to-date inventory and management information 
system and ensuring the use of the data are critical for productivity, effectiveness, and efficiency in the 
institution. This aids in the effort to control costs and helps the hospital to ensure that enough supplies are at 
hand and that stock-out are minimized (Huff, 1996). Records and documentation can be kept in a number of 
ways. Human error can be reduced, lead-time eliminated and data processing improved by the use of 
telecommunication and computer technologies, which should be introduced when available and appropriate.   
 
2.2.8 Transparency in procurement 
The high market value of pharmaceutical products means that the procurement of these products is prone to 
unethical practices such as theft and corruption. Though such practices are common around the world, a number 
of factors predispose developing countries to higher risks. It is estimated that in some countries, up to two thirds 
of all hospital medicines are “lost” through poor procurement practices, including corruption and fraud (Cohen, 
2008: Jillian & Jorge 2001) Unsafe medical products can also enter the hospital with potentially serious health 
consequences.  
Any pharmaceutical procurement must therefore be done in a manner that ensures transparency and a corruption-
free process. In addition, a hospital is often the buying legal entity, and the pharmacist or procurement officer is 
delegated the responsibility to oversee the process. Transparency and adequate reporting builds trust and ensures 
that the relationship between implementers and governance organizations are mutually supportive.  
 
2.2.9. Pharmaceutical procurement in hospital settings 
Pharmaceutical procurement is a complex process that involves many steps and many stakeholders. It is also 
conducted within national and institutional policies, rules, regulations, and structures that may hinder or support 
the overall efficiency of the procurement process. An effective procurement process at any level must ensure that 
four strategic objectives are achieved: the procurement of the most cost effective drugs in the right qualities, the 
selection of reliable suppliers of high-quality products, procurement and distribution systems that ensure timely 
and undisturbed deliveries, and processes that ensure the lowest possible total costs (WHO, 1999). 
Procurement in hospitals is the responsibility of the pharmacist or pharmacy staff, though skills beyond basic 
pharmacy are also required (Karr, 2004). In order to arrive at consensus statements that are appropriate for the 
hospital drug procurement, nine issues have be taken as key areas of attention: transparency, cost containment, 
technical capability, operational principles of good pharmaceutical procurement,  purchasing for safety,  
ensuring appropriate selection, timely, accurate and accessible information,  ensuring quality products, and 
proper budgeting and financing. These respond to the specific needs of the key stakeholders in the hospital 
setting.  
 
2.2.10. Supply of medicines and other pharmaceuticals 
An estimate of the Kenyan pharmaceuticals market by Business Monitor International (BMI) shows15 that 
expenditure on prescription medicines in 2008 was KSh 10.9 billion (US$ 158 million) and that this constituted 
68.7 per cent of the total market. The market share of prescription drugs could rise in future if strict controls are 
introduced on the sale of drugs since many people currently buy such medicines without a prescription. Self-
medication is prevalent in Kenya and the Over the Counter (OTC) market is therefore very important. However, 
while sales volumes are large, OTC medicines are usually low-priced and competition is high. The OTC market 
component was estimated at KSh 4.96 billion (US$ 72 million) and, combining prescription medicines and OTC 
products. 
For purposes of comparison, another market study by Frost and Sullivan (2008) valued the Kenyan market for 
pharmaceuticals at $208.6 million in 2007 and expected it to reach $558.5 million by 2014, growing at a 15.1 per 
cent. The Frost & Sullivan report said that locally manufactured pharmaceutical products commanded 28 per 
cent of the overall pharmaceutical market in 2007, also forecast per capita expenditure on medicines at US$ 5.9 
in 2009, increasing to US$14.1 by 2014. Of the total market in 2008, It estimates that generics would have 
accounted for 58.7 per cent of the total, while original branded pharmaceuticals would have accounted for the 
balance of 41.3 per cent (Frost & Sullivan, 2008). 
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2.2.11 Health institutions in Kenya 
The country continues to have remarkable expansion in the number of health facilities in all provinces. This is in 
line with the government’s effort to avail accessible health facilities and services to all Kenyans. The number of 
health institutions grew from 4,499 in 2002 to 4,557 in 2003, a marginal increase of 1.3%. Rift valley reported 
the highest number of health facilities, with 1,267 (27.8%), while North Eastern province, with 88 health 
facilities had the least number, accounting for 1.9% of the total. Table 2 below illustrates the distribution of 
health facilities in the country by province. 
Table 1: heath institutions in Kenya 2002-2003 
Hospitals, H/centers and H/Sub Centers & Dispensaries 
Province Year  2002  Year 2003 
Nairobi 485 493 
Central 517 526 
Coast 435 440 
Eastern 831 837 
North eastern 83 88 
Nyanza 539 548 
Rift valley 1259 1267 
Western 350 358 
Total 4,499 4,557 
Source: Economic Survey 2004 by Central Bureau of Statistics, Ministry of Planning and National Development 
The World Health Organization estimates the global market for herbal medicines currently stand at over US $ 60 
billion annually and is growing steadily. 
2.3. Critique of the existing literature 
Different researcher have stood to contradict in opinion on the best way towards achieving stability in supply of 
pharmaceutical products; Rivard, (2002) suggested a standard supply chain, while Beaulieu, (2002) put forward 
the view that a stockless inventory system could work best. Stockless inventory systems have clear benefits for 
the hospitals, but still the system does little to optimize operations within the entire supply chain channel. 
Duclos, (1993) performed a study that demonstrated that point of use safety stock was much less effective than 
central store safety stock in preventing stock outs during shock demand situations 
 Huff, (1996) observed that, effectiveness and efficiency on supply chain of pharmaceuticals can be achieved by 
maintaining an up to date inventory and management information system which would ensure that enough 
supplies are at hand and minimize stock-outs; of which that is not the case,; for several factors come in to play 
towards achieving constant supplies and effectiveness and efficiency in supplies in the institutions. In addition 
most researchers have dwelled in trying to develop best ways of cutting procurement costs rather than making 
the purchases available consistently to the intended  users as the core objective of the procurement process        ( 
WHO, 1998; 1999, Kaplan & Laing, 2003). 
 
2.4 Summary 
This chapter has covered the conceptual framework of the study. With major concern on the independent 
variables .i.e. procurement process and its management, legal frame work in relation to procurement of 
pharmaceutical products and procurement procedures, and the dependent variable. Previous studies made by 
other scholars in relation to inventory management in hospital setting and other relevant literature relevant in this 
study. A brief critique of available literature on previous studies has been tackled based on the perceptions and 
understanding of the researcher and a research gap has been developed on other areas, which former researchers 
have not touched in their studies. 
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2.5. Research gaps 
Several studies have been carried out in relation to medical supplies; however, there are little or no theories in 
relation to consistency of supply of pharmaceutical products in government hospitals.  Duclos, (1993) performed 
a study that demonstrated that point-of-use safety stock was much less effective than central store safety stock in 
preventing stock-outs during shock demand situations. In her model, as emergency demand is a characteristic of 
many hospitals business model, the study’s conclusions are cause for concern and question the stockless model. 
 
CHAPTER THREE 
RESEARCH METHODOLOGY 
3.0 Introduction  
In this chapter, details on how the research was conducted have been presented. This includes: research design, 
population, sampling frame, sampling and sampling technique, research instruments, data collection methods, 
data analysis and presentation. 
 
3.1 Research design 
Descriptive research design was used in this study. Descriptive research design was considered best for it is a 
scientific method, which involves observing, describing recording, analyzing and reporting conditions that exists 
without alterations. It can be used to obtain pertinent and precise information concerning the current phenomena 
and where possible to draw valid general conclusions from the facts discovered (Lockesh, 1984). The research 
design adopted was a case study method where the researcher focused on a single organization; It made the 
findings a good representation of real situation. The researcher used both primary and secondary data.  
 
3.2 Population   
The target population included the hospitals top management, pharmacy personnel, nurses, the head or heads of 
procurement department and other staff in the procurement department. 100 questionnaires were distributed and 
only 42 respondents handed back their filled questionnaires representing a 42% response.  
3.3. Sampling frame 
The population was identified as the most relevant group to obtain data from; because of the direct or indirectly 
involvement in the procurement process. In this case, therefore they could avail the required information. 
 
3.4 Sampling and sampling technique 
The researcher used   stratified random sampling; whereby the strata encompassed the personnel of various 
levels cadre in the hospital in relation to procurement; management of the hospital, head of procurement 
department and other staff in the procurement department. To get the sample size from each stratum, simple 
random sampling was used.  
 
3.5 Instruments 
The research main instruments for data collections were structured questionnaires, unstructured interviews and 
secondary data collection. 
 
3.6 Data collection methods 
The research involved data collection from primary and secondary sources. The primary data was collected 
through questionnaires (both open and closed ended) and unstructured interviews. Personal interviews gave an in 
depth into the information; and eliminated misinterpretation.  Questionnaires had the advantage that the 
respondent had adequate time to respond to questions and free from bias because the respondents were guided 
and interviewer did not influence answers. The secondary data were obtained from hospital records, published 
material, journals and internet sources. 
    
3.7 Data analysis and presentation 
The data collected was analyzed by both qualitative and quantitative methods. A quick impressionist summary 
used where the results were obvious and require no further analysis. Quantitative techniques such as percentages 
and frequencies were used.  Tables, graphs and charts were used to present findings where applicable. 
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CHAPTER FOUR 
RESEARCH FINDINGS AND DISCUSSION 
4.1 INTRODUCTION 
This chapter presents the report of data analysis; interpretation and summary of findings. As indicated in chapter 
three, the study utilized descriptive statistics. As such, frequency tables were generated to highlight the 
percentage scores and cumulative percentages for variables of interests. For pictorial presentation, bar graphs 
and pie charts were drawn to enable users to conceptualize the results.  
From the sample size that was selected, the returned questionnaires whose response were used in further 
processing of the data to come up with the research findings included five (10)  managers/supervisors, four (4) 
pharmacists, twenty (25) nurses, three (3) procurement personnel.  
 
4.1.1 Personal and general information analysis 
The researcher undertook to obtain the personal information on the respondent who participated in the study. It 
was important for the researcher to know the particulars for the participants in order to be able to have an 
objective assessment of the findings. Knowing respondents’ information greatly promoted reliability of the data 
obtained for that reflected how well they understood the institution hence a greater level of accuracy and restored 
researcher’s confidence of dealing with the right group. The underlying information concerning the respondents 
who availed their details formed part of the research findings. 
 
4.1.2 Gender of respondents 
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Figure 4.1 Distribution of respondents according to gender 
Most of the respondents 67% were females and 33% where males. It was observed that in every department, 
although females were many compared to males, males were found to be busier than females and were not 
willing to participate in the study hence the great difference between males and females who participated in the 
study. 
 
4.1.3 Job positions 
The respondents were asked to indicate their job position, 24% of the respondents were head of section/mangers, 
10% were pharmacists, 59 % were nurses, and 7% were procurement officers. Nurses formed the largest group 
of 25 respondents; this directly corresponded to their big population in the hospital of one hundred and eighty 
six.  
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Figure 4.2 Job positions of respondents 
All the procurement officers gave their response 100% and they formed the smallest number in the organization 
of three individuals. This information showed that data was obtained from the right individuals and were 
distributed across the hospital departments to minimize biasness. In addition, the researcher was able to identify 
the number of procurement personnel. 
 
4.1.4 Work experience 
The researcher identified that employees work experience had direct influence to the performance of the 
procurement function as a whole. The respondents’ working experience was in 4years range from 0 years to 20 
years and over. Most of the respondents were within the reproductive group of 5 and 16 years of experience.  
 
Table 4.1 work experience of respondents 
Age group  Frequency percentage 
0-4 4 9.5 
5-8 10 23.8 
9-12 12 28.6 
13-16 10 23.8 
17-20 4 9.5 
20 and over 2 4.8 
Total 42 100 
This finding indicated that Majority of the employee were well experience therefore, they understood the 
operations of the institution and their information reflected the true state of affairs in the hospital. In addition, it 
displayed the rate at which the government employed new staff to the hospital. The more experienced one is, is 
attributed to performance hence directly having an impact on the consistency at which suppliers were availed.  
 
4.2 PROCUREMENT PROCESS AND ITS MANAGEMENT 
4.2.1 Organizational chart 
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100% of the respondents indicated that they had no organizational chart of the procurement department. In such 
case therefore, the researcher found out that the hospital had only three procurement personnel who where 
answerable to the hospital administrator. The administrator assigned their duties. This was found to direct affect 
consistency in that there lacked well-designed positions of operations and hierarchy of procurement personnel. 
4.2.2 The extend to which procurement process was observed 
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Figure 4.3 level of adherence to procurement process 
A majority respondent of 74% indicated that the institution had a well-documented procurement process and 
26% indicated no. The respondents were asked whether they fully observed procurement process, 57% of the 
respondents indicated yes, while 43% indicated no; citing the lengthy and bureaucratic nature of the process. this 
findings are supported in the report by WHO, (2008) which identified that all organizations had a well outline 
procurement process and was not fully observed.  This had a direct link to consistency at which supplies were 
made available because when the process was observed, delays were experience while when procured through 
short cuts immediate delivery was attained.   
Inconsistency was evident were by some suppliers were requested through the phone and delivered supplies 
before a local purchase order was prepared. Such cases were necessitated by the urgency of the matter. In 
addition, the procurement department failed in tracking the stock levels hence running into abrupt purchasing 
due to stock outs thus avoiding the documented procurement process. These findings are supported by a study on 
cost containment on pharmaceutical procurement by Huff, (1996); where maintaining an up to date inventory 
record ensure that enough supplies are at hand and minimize stock outs. More over it was found out that the 
government at times used push system and brought to the hospital what it had in stores without consulting the 
hospital whether they needed it or not. Maintaining consistency in supplies was not easy while the hospital 
operated in such situations. 
 
4.2.3 Procedure used in procurement of pharmaceutical products 
Respondents indicated that they used several procedures for procurement, 62% of the respondents indicated that 
they used request for quotation, 23.8% indicated that they used open tendering and 14.2% indicated direct 
tendering was used.   
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 Figure 4.4 procurement procedure used  
Request for quotation was used mostly because it provided the best avenue for the procurement department to 
compare prices and it was fast to carry out. Using different procurement procedures brought in inconsistency for 
each procedure required different time frames and processes to be observed. Open and direct tendering were 
least preferred due to their lengthy process which was time consuming these has been supported by MOH, 
(2004) report which indicates the several steps to be followed in the tendering processes. 
 
4.2.4 Major hospital suppliers and how they performed 
Competence of the suppliers greatly determined consistency in the availability of the supplies. The hospital 
major suppliers were Kenya medical supplies agency (KEMSA), meds and medisel. Kemsa had the big share in 
supplying the hospital these findings were confirmed by CBS and MOH, (2004) which cited that kemsa was 
established by law as the primary public procurement agency for medical supplies. 100% of the respondents 
indicated that the suppliers delivered the products to the hospital premises. however responses where varied on 
timely delivery with 38% indicating that there were delays in delivery, 24% indicating that some delayed and 
others where delivered on time and 38% indicating that delivery was made on time.  
Frequent delays lead to inconsistency in obtaining supplies. Delays were caused by the processes of initiating a 
request for supplies to the supplier, non availability of some pharmaceuticals from the Kenyan market or in the 
global market, legislation issues also come in to play as these products had to be authorized to be used in Kenyan 
market hence delays while awaiting approval and other logistical issues . 
It was found out that some supplies took less than 48 hours to be delivered at the hospital premises when 
contracted courier services were used thus being fast enough to avert any shortages.  At times suppliers failed to 
supply goods order due to lack of payment by the hospital in the previous deliveries made and stock-outs, which 
was most experienced with KEMSA. These factors lead to great inconsistency in obtaining supplies.  All the 
respondents felt that products supplied corresponded with the specifications given to suppliers; were of good 
quality and at no time did the user department reject them. In addition, products were not tampered with on 
transit and delivery was made at the hospital as dispatched by the supplier. 
 
4.2.5 Factors considered in Supplier evaluation 
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Figure 4.5 supplier evaluation factors 
Performance indicators were given the scales of 1, 2, 3,4and 5 with 1 being not important factor toward 5 the 
extremely important factor to consider. Supplier’s capacity to supply had great impact on consistency in supply 
of pharmaceuticals to the hospital. Majority of the respondents, 42.7% indicated that supplier reliability to 
supply was a key factor for consideration when evaluating suppliers; and 5% indicating that it was not an 
important factor to consider. 38.4% of the respondents indicated that supplier’ service quality in terms of 
flexibility, responsiveness and availability; and at least 7% indicating it was not an important factor. On ISO 
certification, a majority of 35.7% indicated that it was not an important factor to consider when evaluating a 
supplier; and a 7% indicating that it was an important factor. 
These findings confirm a report by WHO, (1999) where several parameters are used in supplier evaluation. 
These clearly depicted that the hospital was to some extend concerned about suppliers ability to supply. They 
had little concern on ISO certification of supplier because they viewed it as less importance and of non-value 
adding to supplier’s ability to supply. Other factors identified as considered included the pricing of the supplier 
products, (where by the lowest was selected), ability of the supplier to supply on credit, the suppliers past 
records, honest and efficiency of the supplier. 
 
4.2.6 Sources of finance and their impact   
The hospital received finances from the government, donors and own savings (collections from patients which 
the hospital sought authority to spend to certain limits). 100% of the respondents indicated that the source of 
finance influenced timely availability of supplies. Delays culminating from availability of funds were 
experienced as indicated in table 4.2 below. 
Table 4.2 frequency of supplier delays  
Extend experienced Frequency percentage 
Frequently 22 52.4 
Sometimes 11 26.2 
Rarely 9 21.4 
Total 42 100 
The respondents indicated that they experienced delays in supply of pharmaceutical products because of the 
following reasons: late payment to suppliers hence de-motivating them, insufficiency of funds to meet demands, 
late budgeting and awaiting government approval to spend the funds hence put on hold the procurement process. 
Developing Country Studies                                                                                                                                                              www.iiste.org 
ISSN 2224-607X (Paper) ISSN 2225-0565 (Online) 
Vol.3, No.13, 2013 
 
37 
 
All these factors relating to the source of finance directly influenced the consistency level of supplies. This 
findings are supported by the study by CBS and MOH, (2004) which identified that based on available funds 
essential medicines can not be purchased due to financial constrains. 
 
4.2.7 Buyer Supplier relationship 
The majority of respondent ranked low relationship between the institution and suppliers with 50%,which had a 
direct negative influence towards consistency in supplies,  31% moderate and 19% ranking the relationship as 
high. This has been represented in the figure below. 
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Figure 4.6-buyer supplier relationship 
They gave the following as the reasons for ranking the relationship low between them as:  payments to suppliers 
were always delayed hence de-motivating the suppliers, there was no personal relationship between the 
procurement personnel and the suppliers due to the organizational setting and in most of the cases there were no 
repeat suppliers except KEMSA. 
 
4.3.1 INFLUENCE OF LEGAL POLICY ON PROCUREMENT 
90.5% of the respondents indicated that the legal requirements lengthened the procurement process negatively 
affecting the consistency levels. The government financial regulations required that no expenditure would be 
incurred without authority to incur expenditure. In that regard therefore, at times the hospital had to wait for the 
official communication from the relevant authorities to spend money on purchases. No orders would be made in 
anticipation for money to be availed for that was against the financial regulations. Where by the A.I.E would be 
availed early enough but the funding would delay or at times never be funded these seriously interfering with the 
consistency of obtaining supplies. 
In addition, the hospital was not supposed to incur expenses that surpassed the government funding. In that case 
therefore, it was found out that the hospital had to request for approvals and funding at any time the institution 
had to incur un allocated expenses in procurement. 95% of the respondents felt that they observed to the later 
government regulations in relation to procurement while 5% viewed that the regulations where not fully 
observed.  
 
4.3.2 Challenges faced in complying with legal requirements 
Several challenges identified included; delays in obtaining A.I.Es’ (authority to incur expenditure) or delayed 
funding, insufficient funding, bureaucracy in the legal requirements, and dealing with exploitive prequalified 
suppliers. Operations at the hospital could have been smoother if these problems were put to rest. These 
challenges were found to have contributed to the high level of inconsistency experienced in the hospital. 
 
4.3.3 Role of legal regulations in procurement process 
Developing Country Studies                                                                                                                                                              www.iiste.org 
ISSN 2224-607X (Paper) ISSN 2225-0565 (Online) 
Vol.3, No.13, 2013 
 
38 
 
The government legal regulations were found to have an influence on the level of consistency of supplies 
experienced in the hospital. The legal policies have enhanced accountability for they outline and government 
spending of public funds and realizations of value for money spend. These findings support a study by Rafael 
and Ernest, (2002) which pinpoints out that legal framework help in minimizing public funds embezzlement. In 
addition, they give out a well-outlined procurement procedure that had to be followed by all hospitals in 
procurement. Transparency was also enhanced in all procurement dealings. It was found out that government 
polices and regulations provided timelines for order fulfillment. 90.5%of the respondents indicated that the 
government policies and regulations provided concrete guidelines on pharmaceutical procurement while 9.5% 
indicated that they did not. Public procurement and disposal Act 2005 came in to play as the basis of all public 
procurement. 
4.4 METHODS OF ENHANCING PROCUREMENT PROCEDURES 
4.4.1 The extend of internal tools usage towards increased performance.  
Table 4.3 Internal tools level of usage  
 level of  usage Not Rarely Often Usually Core total 
Attempting to contribute to R & 
D 
10% 20% 6% 6% 0 100% 
Attempting  high employee 
productivity 
14.3% 19% 42.9% 19% 4.8% 100% 
Attempting E-procurement 95.5% 4.8% 0 0 0 100% 
Minimize ordering  time 7.1% 23.8% 50% 14.3% 4.8% 100% 
Optimizing the amount of 
contract 
57.1% 21.4% 12% 9.5% 0 100% 
Minimize amount of suppliers 23.8% 50% 19% 7.2% 0 100% 
Emphasizing buyer supplier 
relationship 
7.1% 11.9% 42.9% 26.2% 11.9% 100% 
Minimize maverick spending 5% 9.5% 57.2% 16.3% 12% 100% 
 
Several internal tools were posed to respondents to indicate to what level do they apply/ use them to improve the 
performance of procurement system. The level of usage were not used, rarely used, often, usually, and a core 
tool.  The responses were as follows:  20% majority indicated that rarely did they attempt to contribute to 
research and development. To some extend the institution often attempted achieving high employee productivity. 
42.9% of the respondents indicated often. That was an indication that some effort was being put in place to 
improve performance. It was identified that the hospital never attempted e-procurement where 95.5% indicated 
not used. 
50% of respondents indicated the hospital was attempting to minimize the period from receiving the purchase 
order to submitting the purchase order to the suppliers. A minimal of 4.8% indicated that this was a core tool to 
the hospital. The hospital did little to attempt to optimize the amount of contracts as per product group with a 
57.1% indicating not used and 9.5% indicating usually used. A majority of 50% indicated that the hospital rarely 
attempted minimizing the amount of suppliers as per product group and 42.9% and 57.2% majority indicated that 
often the hospital attempted emphasizing the importance of the buyer supplier relationship and attempted 
minimizing maverick spending( purchasing outside the preferred contracts) respectively. To an extend 
implementation of these tools helped improve the level of consistency and vice versa. these findings confirms a 
study by Rafael and Ernesto, (2002) and Cohen, (2008) which provides many tools for improving health system 
performance.  
 
4.5. Problems facing procurement process 
100% of the responded cited that the hospital lacked enough staff to carry out procurement roles. It was observed 
that the procurement department had three (3) personnel. Every individual in this department was forced to do 
extra different duties to meet the demands of the department. The researcher found out that the individual who 
was in charge of goods verification from the supplier was also in charge of releasing products to the pharmacy 
and writing and issuing of local purchase orders to suppliers. In this case therefore, little or no control was 
exercised in the procurement process. In addition, delays occurred for such an individual had a lot of work to do. 
These problems led to great levels of inconsistency of supplies in the hospital.  
 
4.6. Recommendations for improvements of procurement process  
Respondents suggested for a committee to be formed that would oversee and evaluate all the suppliers and 
prequalify them every six months, they pointed out that the procurement process was left to certain individuals. 
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20% of the respondents cited that the procurement procedures were bureaucratic and needed review to enhance 
flexibility and quick purchase of pharmaceuticals when needed. Majority of the nurses felt that the procedures of 
procurement where not clear, in that case therefore they needed some training to help them to fully understand 
them.  
100% of the section heads/managers who gave their response pointed out that it was difficult to manage the 
stock levels and procurement process because it was not automated thus led to un anticipated shortages of stocks. 
Several loopholes led to embezzlement of funds and un necessary delays where experienced. They felt that if 
automation was put in place it would eliminate such delays and improve the performance of the procurement 
department. In addition, they needed more training of all staff in relation to procurement.  
The availability of funds needed to be addressed to improve the operations of the procurement process, because 
in most cases funds were the major impediments to timely supply of pharmaceuticals. Moreover, as identified by 
CBS and MOH (2004), insufficiency of funds needed to be addressed by the government for in most cases fund 
could not meet the demands of the hospital. The following areas where indentified as the areas that needed to be 
addressed:  reliability of suppliers, emergency kitty for emergency cases, increasing the number of procurement 
staff and training of staff in relation to procurement. If these recommendations were addressed, inconsistency 
would have been eliminated or minimized to negligible levels and boost service delivery of the institution. 
 
 
CHAPTER FIVE 
SUMMARY, CONCLUSIONS AND RECOMMEDATIONS 
5.1 Introduction 
This chapter deals with summary, conclusion and recommendations. Conclusions were drawn from the answers 
that the research sought to understand. Recommendations were based on the conclusions drawn while assessing 
the factors affecting consistency in supply of pharmaceutical products in government hospital.  
 
5.2 Summary 
The study set out to establish the factors that affected consistency in supply of pharmaceutical products in 
government hospitals, with a case study of Maragua district hospital. The research involved use of qualitative 
and quantitative research method to achieve the objectives. The researcher used both primary and secondary 
data. The sample size selected of 100 individuals had a 42% response that formed the researchers’ database. 
 
5.2.1 Summary of procurement process and its management 
 The researcher found that the hospital had a well-documented procurement process, which was not fully 
observed. The procurement department was understaffed with only thee personnel who were in charge of all the 
hospital procurements. Mostly the hospital used request for quotations to procure pharmaceuticals along side 
direct tendering and open tendering. At times, these procurement procedures were not followed and shortcuts 
were used to obtain supplies. The researcher found that some supplies delayed while others were delivered on 
time. However, in some cases, the suppliers never supplied at all the products ordered due to stock-outs in the 
market and un paid previous supplies made caused by lack of funds in the hospital or delayed funding. Record 
keeping was poor and manually done. Quality of products was good and at no time did the user department reject 
them. 
The researcher established that supplier reliability to supply and supplier service quality measured in terms of 
flexibility, responsiveness and availability were key factors considered in supplier evaluation; where as the 
hospital did not consider ISO certification of suppliers as an important factor. Other factors considered included, 
pricing, honesty and efficiency of the supplier. Government funding, donations and own collections were the 
hospital sources of finance. The source of finance and legal requirements greatly determined the timely 
availability of supplies following the availability of money and the required procedures observed towards 
spending respectively.  
 
5.2.2 Summary on influence of legal policy 
It was evident that the legal policy requirements was bureaucratic, lengthened the procurement process and led to 
delays in obtaining supplies for the relevant procedures had to be observed especially in obtaining and spending 
of money. Delays in obtaining A.I.Es and their funding was a major challenge. However, the legal policy 
requirements provided well-stipulated guidelines on public procurement.  
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5.2.3 Summary on methods of enhancing procurement procedures 
 The researcher identified that the institution was doing little on; contributing to research and development, 
attempting e-procurement, optimizing the amount of contracts and suppliers as per product group. In addition, 
the hospital often did attempt to; achieve high employee productivity, minimize the period from receiving 
purchase order to submitting the purchase order to the supplier, emphasize the importance of the relationship 
with suppliers, and minimize maverick spending.  
 
5.3 Conclusions 
Procurement process was well documented as was evident with a 100% response, but was not fully observed at 
times short cuts were used in obtaining supplies; and its management was wanting as indicated by 57% of the 
respondents. Short cuts were used to ensure replenishment of stocks was achieved by evading the procurement 
process. Stock records were not fully kept and the rate of consumption was not closely monitored which lead to 
stock outs due to delays in placing an order; this was evidently pointed out by the supervisors/mangers who gave 
their response. Operations of the procurement department could not be any better due to the level of 
understaffing observed. Inconsistency in supply of pharmaceuticals was widely experienced culminating from 
bureaucratic procurement procedures and legal requirements whereby 90.5% indicated that the legal 
requirements lengthened the procurement process.  52.4% of respondents indicated frequent delays were 
experienced in obtaining supplies, which was because of; delayed funding, insufficient funding, and shortage of 
staff to carry out the procurement function as identified in the findings in the previous chapter. Low buyer 
supplier relationship existed as indicated by 50% of respondents. Lack of e-procurement which could have been 
fast, and stock-outs on the suppliers side or in the global market. It was evident the institution was not making 
great efforts in using internal tools towards improving procurement performance for none was a core tool. 
Training was also required to all stakeholders in the hospitals on matters of procurement for majority of the 
nurses and supervisors cited that they needed more training to boost performance.  
 
5.4 Recommendations 
To enhance consistency the study recommends to the Ministry of Medical Services, 
Ministry of Public Health and Sanitation, and other stakeholders to: 
i.Enforce the laid down procurement procedures in all hospitals by conducting regular audits. It was evident that 
at times, the procurement procedures were not fully observed and short cuts were used to ensure products 
reached the hospital. 
ii.Ensure that all public health hospitals adequate personnel, for the researcher identified that, there were only three 
procurement staff and the department had no organizational charter. Mostly the head of departments had to 
follow up on what their department needed. 
iii.Reduce bureaucracy and try as would be practicable to minimize the lengthy legal requirements. Majority of the 
respondents cited that the legal requirements were lengthy and bureaucratic to follow. 
iv.Increase budgetary allocation and facilitate timely availability of funds for use to the hospitals, because the 
researcher identified that the funds channeled to the hospital were not enough and in most cases delayed in 
funding. 
v.Instill and develop a culture of good buyer- supplier relationship in the hospitals. It was evident that the buyer 
supplier relationship was low and in most cases there was no repeat supplier except KEMSA. 
vi.Train all staff in the hospital on matters of procurement to enhance the performance of the procurement function. 
 
5.5 Suggestion for Further Research 
i) There is need for a study to determine to what extend do all the hospital procurement players understand the 
procurement function. 
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APPENDICES 
APPENDIX I:  QUESTIONAIRE 
Dainiel Muia Mutua, 
Jomo Kenyatta University of agriculture & Technology 
P.O. BOX 6200-00200, 
Nairobi. 
Mobile No. 0726 130 906 
Dear respondent, 
I am a student of the above mentioned University and pursuing a Master’s Degree in Procurement and Logistics. 
I am requesting for candid information on the attached questionnaire to facilitate my research on “factors 
affecting consistency in supply of pharmaceutical products in government hospitals: A case study Maragua 
district hospital”. Duly completed questionnaires can be handed back to me.  
I look forward for your favourable response and I pledge utmost confidentiality to information given. Thanks in 
advance for your time. 
 
Yours sincerely, 
DANIEL MUIA MUTUA 
Developing Country Studies                                                                                                                                                              www.iiste.org 
ISSN 2224-607X (Paper) ISSN 2225-0565 (Online) 
Vol.3, No.13, 2013 
 
43 
 
 
 
Developing Country Studies                                                                                                                                                              www.iiste.org 
ISSN 2224-607X (Paper) ISSN 2225-0565 (Online) 
Vol.3, No.13, 2013 
 
44 
 
  
 
 
 
Developing Country Studies                                                                                                                                                              www.iiste.org 
ISSN 2224-607X (Paper) ISSN 2225-0565 (Online) 
Vol.3, No.13, 2013 
 
45 
 
 
 
Developing Country Studies                                                                                                                                                              www.iiste.org 
ISSN 2224-607X (Paper) ISSN 2225-0565 (Online) 
Vol.3, No.13, 2013 
 
46 
 
 
Developing Country Studies                                                                                                                                                              www.iiste.org 
ISSN 2224-607X (Paper) ISSN 2225-0565 (Online) 
Vol.3, No.13, 2013 
 
47 
 
Developing Country Studies                                                                                                                                                              www.iiste.org 
ISSN 2224-607X (Paper) ISSN 2225-0565 (Online) 
Vol.3, No.13, 2013 
 
48 
 
 
Developing Country Studies                                                                                                                                                              www.iiste.org 
ISSN 2224-607X (Paper) ISSN 2225-0565 (Online) 
Vol.3, No.13, 2013 
 
49 
 
 
Developing Country Studies                                                                                                                                                              www.iiste.org 
ISSN 2224-607X (Paper) ISSN 2225-0565 (Online) 
Vol.3, No.13, 2013 
 
50 
 
Developing Country Studies                                                                                                                                                              www.iiste.org 
ISSN 2224-607X (Paper) ISSN 2225-0565 (Online) 
Vol.3, No.13, 2013 
 
51 
 
Developing Country Studies                                                                                                                                                              www.iiste.org 
ISSN 2224-607X (Paper) ISSN 2225-0565 (Online) 
Vol.3, No.13, 2013 
 
52 
 
This academic article was published by The International Institute for Science, 
Technology and Education (IISTE).  The IISTE is a pioneer in the Open Access 
Publishing service based in the U.S. and Europe.  The aim of the institute is 
Accelerating Global Knowledge Sharing. 
 
More information about the publisher can be found in the IISTE’s homepage:  
http://www.iiste.org 
 
CALL FOR JOURNAL PAPERS 
The IISTE is currently hosting more than 30 peer-reviewed academic journals and 
collaborating with academic institutions around the world.  There’s no deadline for 
submission.  Prospective authors of IISTE journals can find the submission 
instruction on the following page: http://www.iiste.org/journals/   The IISTE 
editorial team promises to the review and publish all the qualified submissions in a 
fast manner. All the journals articles are available online to the readers all over the 
world without financial, legal, or technical barriers other than those inseparable from 
gaining access to the internet itself. Printed version of the journals is also available 
upon request of readers and authors.  
MORE RESOURCES 
Book publication information: http://www.iiste.org/book/ 
Recent conferences:  http://www.iiste.org/conference/ 
IISTE Knowledge Sharing Partners 
EBSCO, Index Copernicus, Ulrich's Periodicals Directory, JournalTOCS, PKP Open 
Archives Harvester, Bielefeld Academic Search Engine, Elektronische 
Zeitschriftenbibliothek EZB, Open J-Gate, OCLC WorldCat, Universe Digtial 
Library , NewJour, Google Scholar 
 
 
